Jorge A. Marrero
Corresponding Author: Jorge A. Marrero
Division of Gastroenterology
University of Michigan
3912 Taubman Center
Name/email consistency: high
- Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Singal, A.G., Conjeevaram, H.S., Volk, M.L., Fu, S., Fontana, R.J., Askari, F., Su, G.L., Lok, A.S., Marrero, J.A. Cancer Epidemiol. Biomarkers Prev. (2012)
- The challenge of prognosis and staging for hepatocellular carcinoma. Marrero, J.A., Kudo, M., Bronowicki, J.P. Oncologist (2010)
- Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Marrero, J.A., Feng, Z., Wang, Y., Nguyen, M.H., Befeler, A.S., Roberts, L.R., Reddy, K.R., Harnois, D., Llovet, J.M., Normolle, D., Dalhgren, J., Chia, D., Lok, A.S., Wagner, P.D., Srivastava, S., Schwartz, M. Gastroenterology (2009)
- Modern diagnosis and management of hepatocellular carcinoma. Marrero, J.A., Welling, T. Clin. Liver. Dis (2009)
- Hepatocellular carcinoma. Marrero, J.A. Curr. Opin. Gastroenterol. (2006)
- Hepatocellular carcinoma. Marrero, J.A., Pelletier, S. Clin. Liver. Dis (2006)
- Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Marrero, J.A., Hussain, H.K., Nghiem, H.V., Umar, R., Fontana, R.J., Lok, A.S. Liver Transpl. (2005)
- Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Marrero, J.A., Fontana, R.J., Barrat, A., Askari, F., Conjeevaram, H.S., Su, G.L., Lok, A.S. Hepatology (2005)
- Screening tests for hepatocellular carcinoma. Marrero, J.A. Clin. Liver. Dis (2005)
- GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. Marrero, J.A., Romano, P.R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C.J., Comunale, M.A., D'Amelio, A., Lok, A.S., Block, T.M. J. Hepatol. (2005)
- Newer markers for hepatocellular carcinoma. Marrero, J.A., Lok, A.S. Gastroenterology (2004)
- Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Marrero, J.A., Su, G.L., Wei, W., Emick, D., Conjeevaram, H.S., Fontana, R.J., Lok, A.S. Hepatology (2003)
- Hepatocellular carcinoma. Marrero, J.A. Curr. Opin. Gastroenterol. (2003)
- NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Marrero, J.A., Fontana, R.J., Su, G.L., Conjeevaram, H.S., Emick, D.M., Lok, A.S. Hepatology (2002)